Dr. Postow On Nivolumab Combined With Ipilimumab In Melanoma

Dr. Postow on Nivolumab Combined With Ipilimumab in Melanoma

Ipilimumab Combined With Nivolumab for Patients With Melanoma

Targeted Oncology

Dr. Postow on OS Results of CheckMate-069 Study

Dr. Postow on the Current Treatment Landscape in Melanoma

Dr. Hodi on Nivolumab in Combination With Ipilimumab for Advanced Melanoma

Dr. Sznol on Combining Nivolumab and Ipilimumab for the Treatment of Advanced Melanoma

Nivolumab plus ipilimumab continues to improve OS, PFS at 2 years in patients with advanced melanoma

Dr. Sznol Discusses the Combination of Ipilimumab and Nivolumab in Melanoma

New Checkpoint Inhibitors & Immunotherapy in Metastatic Melanoma - Michael Postow MD

Combining nivolumab and ipilimumab in patients with resected stage IV melanoma

Dr. Michael Postow on the Toxicities of Melanoma-Treating Targeted Therapy Combinations

Targeted Oncology

Dr. Luke Discusses the Controversy Surrounding Ipilimumab/Nivolumab Combo in Melanoma

Dr. Sznol on Combining Nivolumab and Ipilimumab for the Treatment of Advanced Melanoma

Targeted Oncology

Dr. Ernstoff Discusses Nivolumab and Ipilimumab in Advanced Melanoma

Dr. Long on Nivolumab/Ipilimumab in Patients with Melanoma Brain Metastases

Dr. Ott Discusses Ipilimumab and Nivolumab in Melanoma

New Long-term Data 'Clearly Favor' Combination Ipilimumab/Nivolumab in Melanoma

Nivolumab Plus Ipilimumab in Advanced Melanoma

Checkmate 067 - combined nivolumab and ipilimumab

Success for ipilimumab and nivolumab combo in advanced melanoma